12/11/2023 12:52:47 PM - This India-based firm in the Medical - Generic Drugs industry group gapped down today violating its 50 DMA line ($66.68). It was perched within striking distance of its 52-week high when noted with caution in the 12/06/23 mid-day report - <i>"Reported Sep &#39;23 quarterly earnings +30% on +7% sales revenues versus the year-ago period. Prior quarterly and annual earnings history (<strong>C</strong> and <strong>A</strong> criteria) leaves fundamental concerns."</i><br><hr>12/6/2023 12:35:57 PM - This India-based firm in the Medical - Generic Drugs industry group perched within striking distance of its 52-week high after consolidating since last noted with caution in the 8/17/23 mid-day report. Reported Sep &#39;23 quarterly earnings +30% on +7% sales revenues versus the year-ago period. Prior quarterly and annual earnings history (<strong>C</strong> and <strong>A</strong> criteria) leaves fundamental concerns.<br><hr>8/17/2023 1:48:25 PM - This India-based firm in the Medical - Generic Drugs industry group is hovering near its 52-week high stubbornly holding its ground following noted volume-driven gains. Reported Jun &#39;23 quarterly earnings +13% on +24% sales revenues versus the year-ago period. Prior quarterly and annual earnings history (<strong>C</strong> and <strong>A</strong> criteria) leaves fundamental concerns.<br><hr>8/16/2023 12:34:24 PM - This India-based firm in the Medical - Generic Drugs industry group is hovering near its 52-week high following noted volume-driven gains. Reported Jun &#39;23 quarterly earnings +13% on +24% sales revenues versus the year-ago period. Prior quarterly and annual earnings history (<strong>C</strong> and <strong>A</strong> criteria) leaves fundamental concerns.<br><hr>8/10/2023 12:34:37 PM - This India-based firm in the Medical - Generic Drugs industry group is hitting another new 52-week high with today&#39;s 3rd consecutive volume-driven gain. Reported Jun &#39;23 quarterly earnings +13% on +24% sales revenues versus the year-ago period. Prior quarterly and annual earnings history (<strong>C</strong> and <strong>A</strong> criteria) leaves fundamental concerns.<br><hr>8/8/2023 1:20:47 PM - This India-based firm in the Medical - Generic Drugs industry group is hitting a new 52-week high today. Reported Jun &#39;23 quarterly earnings +13% on +24% sales revenues versus the year-ago period. Prior quarterly and annual earnings history (<strong>C</strong> and <strong>A</strong> criteria) leaves fundamental concerns.<br><hr>5/10/2023 12:42:43 PM - Gapped down today testing its 50 DMA line ($57.34). This India-based firm in the Medical - Generic Drugs industry group reported Dec &#39;22 quarterly earnings +59% on +15% sales revenues versus the year-ago period. Prior quarterly and annual earnings history (<strong>C</strong> and <strong>A</strong> criteria) leaves fundamental concerns.<br><hr>3/20/2023 12:38:17 PM - This India-based firm in the Medical - Generic Drugs industry group reported Dec &#39;22 quarterly earnings +59% on +15% sales revenues versus the year-ago period. Prior quarterly and annual earnings history (<strong>C</strong> and <strong>A</strong> criteria) leaves fundamental concerns.<br><hr>2/28/2014 12:55:26 PM - Perched near its 52-week high today following <strong>4</strong> consecutive volume-driven gains into new high territory. The <strong>2</strong> prior mid-day reports cautioned members - <em>&quot;No overhead supply remains to act as resistance. This India-based firm in the Medical - Generic Drugs industry group has not shown strong and steady quarterly and annual earnings increases (<strong>C</strong> and <strong>A</strong> criteria).&quot; </em><br><hr>2/27/2014 12:54:46 PM - Rallying for another new 52-week high with today&#39;s <strong>4</strong>th consecutive gain adding to a spurt of volume-driven gains into new high territory. The 2/26/14 mid-day report cautioned members - <em>&quot;No overhead supply remains to act as resistance. This India-based firm in the Medical - Generic Drugs industry group has not shown strong and steady quarterly and annual earnings increases (<strong>C</strong> and <strong>A</strong> criteria).&quot; </em><br><hr>2/26/2014 1:24:36 PM - Gapped up today rallying for new 52-week highs with a <strong>3</strong>rd consecutive gain adding to a spurt of volume-driven gains into new high territory. No overhead supply remains to act as resistance. This India-based firm in the Medical - Generic Drugs industry group has not shown strong and steady quarterly and annual earnings increases (<strong>C</strong> and <strong>A</strong> criteria).<br><hr>1/19/2010 12:51:09 PM - Gapped down today, pulling back after steadily rallying to a new 52-week high.  No overhead supply remains to act as resistance. As noted in prior mid-day report appearances, &quot;<em>this Indian firm in the Medical - Ethical Drugs industry group has a poor annual earnings history (<strong>A</strong> criteria).</em>&quot;<br><hr>1/7/2010 12:34:06 PM - Hovering near its 52-week high with no overhead supply to act as resistance. As noted in prior mid-day report appearances, &quot;<em>this Indian firm in the Medical - Ethical Drugs industry group has a poor annual earnings history (<strong>A</strong> criteria).</em>&quot;<br><hr>1/6/2010 12:47:34 PM - Gapped up today, rallying near its 52-week high. As noted in prior mid-day report appearances, &quot;<em>this Indian firm in the Medical - Ethical Drugs industry group has a poor annual earnings history (<strong>A</strong> criteria).</em>&quot;<br><hr>12/23/2009 12:35:21 PM - Consolidating quietly near its 52-week high after gains last week with above average volume. As noted in prior mid-day report appearances, &quot;<em>this Indian firm in the Medical - Ethical Drugs industry group has a poor annual earnings history (<strong>A</strong> criteria).</em>&quot;<br><hr>12/18/2009 12:37:58 PM - Gapped up today and hit a new 52-week high. As noted in prior mid-day report appearances, &quot;<em>this Indian firm in the Medical - Ethical Drugs industry group has a poor annual earnings history (<strong>A</strong> criteria).</em>&quot;<br><hr>12/4/2009 12:56:53 PM - Trading lower after recently hitting a new 52-week high on 12/1/09. As noted in <strong>4</strong> prior mid-day report appearances this month, &quot;<em>this Indian firm in the Medical - Ethical Drugs industry group has a poor annual earnings history (<strong>A</strong> criteria).</em>&quot;<br><hr>11/17/2009 1:40:18 PM - Multiple gains with above average volume have recently lifted it to new 52-week and new all-time highs. As noted in <strong>3</strong> prior mid-day report appearances this month, &quot;<em>this Indian firm in the Medical - Ethical Drugs industry group has a poor annual earnings history (<strong>A</strong> criteria).</em>&quot;<br><hr>11/11/2009 12:46:44 PM - Multiple gains with above average volume have recently lifted it to new 52-week and new all-time highs, but this Indian firm in the Medical - Ethical Drugs industry group has a poor annual earnings history (<strong>A</strong> criteria).<br><hr>11/10/2009 12:31:37 PM - Multiple gains with above average volume have recently lifted it to new 52-week and new all-time highs, but this Indian firm in the Medical - Ethical Drugs industry group has a poor annual earnings history (<strong>A</strong> criteria).<br><hr>11/2/2009 12:39:39 PM - Multiple gains with above average volume have recently lifted it to new 52-week and new all-time highs. Indian firm in theMedical - Ethical Drugs industry group has a poor annual earnings history.<br><hr>10/26/2009 1:39:12 PM - Poor annual earnings history.<br><hr>